Disrupting Type IV secretion function to prevent virulence in the pathogenic bacterium Legionella pneumophila
Disrupting Type IV secretion function to prevent virulence in the pathogenic bacterium Legionella pneumophila
批准号:
10269713
负责人:
Anton Simeonov
金额:
$18.66万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Alveolar MacrophagesAmoeba genusBiological AssayCellsCoxiellaEnvironmentFresh WaterGrowthImmune responseInfectionLegionella pneumophilaLegionnaires&apos DiseasePneumoniaProcessProteinsReporterSignal TransductionSystemToxinType IV Secretion System PathwayValidationVirulencedesignnovel therapeuticspathogenpathogenic bacteriapreventscreeningsmall moleculetrafficking
中文摘要
在此期间,项目团队设计了一种新的筛选方法,该方法强烈支持通过直接靶向细菌T4SS而不是宿主细胞内的过程来鉴定干扰报告易位过程的化合物。成功完成了对数万个分子的初步筛选,并对命中分子进行了精心挑选和重新测试以进行验证。进一步评估选择的命中物以确定它们在需要功能性T4SS的多种生物测定中的功效,例如在伯内特考克斯氏菌中。
英文摘要
During this period, the project team designed a new screening approach that strongly favored identification of compounds that interfere with the process of reporter translocation by directly targeting the bacterial T4SS rather than processes within host cells. Primary screening of tens of thousands of molecules was successfully completed, and hit molecules were cherry-picked and retested for validation. Select hits were further assessed to determine their efficacies in a variety of biological assays that require a functional T4SS, for example in Coxiella Burnetti.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Compound for Targeted Treatment of CBF Leukemia
-
批准号:9205569
-
项目类别:
-
资助金额:$200.38万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Profliing Assay for Redox Potential
-
批准号:9772066
-
项目类别:
-
资助金额:$4.08万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of Myc translation inhibitors
-
批准号:9554527
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Trans-NIH RNAi Facility (TNRF)
-
批准号:9205806
-
项目类别:
-
资助金额:$47.5万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of Grb10:Insulin Receptor Disruptors
-
批准号:9554524
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
PRKACA for Fibrolamellar hepatocellular carcinoma
-
批准号:9554490
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
MST/ITC studies on Vimentin DHA interaction
-
批准号:9554499
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Disrupting Type IV secretion function to prevent virulence in the pathogenic bacterium Legionella pneumophila
-
批准号:9554502
-
项目类别:
-
资助金额:$13.57万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
A Novel Compound for Targeted Treatment of CBF Leukemia
-
批准号:9550575
-
项目类别:
-
资助金额:$205.31万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Protein Kinase CAMP-Activated Catalytic Subunit Alpha
-
批准号:9554489
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
High-throughput multiparametric drug screening method for 3D spheroids
-
批准号:9554522
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Functional Genomics Laboratory (FGL)
-
批准号:10682312
-
项目类别:
-
资助金额:$107.78万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
15-hLO-1 inhibitors as Potential Therapeutics Against Stroke
-
批准号:10011389
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Screening to identify potent and specific inhibitors of N-terminal methyltransferase (NTMT1) as chemical probes
-
批准号:10011397
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of small molecule inhibitors of USP8
-
批准号:10011437
-
项目类别:
-
资助金额:$4.76万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Assay Guidance Manual
-
批准号:10011458
-
项目类别:
-
资助金额:$3.37万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of inhibitors of Zika Protease (NS2B-NS3)
-
批准号:10005788
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Activation-induced cytidine deaminase
-
批准号:10011394
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
qHTS to Identify Inhibitors of Rabies Virus
-
批准号:10011405
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Aminoadipate semialdehyde synthase as a therapeutic target for pyridoxine dependent epilepsy
-
批准号:10269700
-
项目类别:
-
资助金额:$11.24万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位: